Survey: 71% of CBD users self-determine dosage without consulting a professional

By Danielle Masterson contact

- Last updated on GMT

Getty Images /  Luke Chan
Getty Images / Luke Chan

Related tags: Cbd, dosage forms

Although the 2018 Farm Bill legalized the use of hemp and its products, it didn’t amend the Food, Drug and Cosmetic Act to permit the use of hemp or hemp-derived products in dietary supplements. This lack of oversight has left a gaping hole in the industry, with brands and consumers left to interpret CBD dosing themselves.

Last year representatives Kurt Schrader (D-OR) and Morgan Griffith (R-VA) introduced the Hemp and Hemp-Derived CBD Consumer Protection & Market Stabilization Act. In February, Rep. Schrader re-introduced the bill, which aims to allow CBD and other hemp-derived products to lawfully be used in dietary supplements under the Federal Food, Drug and Cosmetic Act. This bill prioritizes consumer safety, requiring manufacturers to comply with existing federal regulations for dietary supplements and ensuring that products are properly labelled and prepared. 


CBD regulations would also help standardize safe amounts of CBD. Because consumers often reach for CBD for a multitude of effects, dosage depends on not only what benefit consumers are seeking, but also format, bioavailability and genetic factors such as microbiome health. 

With no uniformity for dosing, Leafreport decided to ask consumers how they gauge CBD amounts​. Via SurveyMonkey, the consumer watchdog group surveyed over a thousand individuals in the US. Those who hadn’t used CBD before were disqualified from the survey, leaving 721 participants remaining.

Key Findings

  • 71% determined the dosage themselves without consulting a professional
  • 26% do not check for CBD concentration when shopping for CBD products
  • 22% do not check the dose before taking CBD
  • 29% of CBD users consulted with a professional to determine dosage
  • 48% tend to take the same dosage every time they consume CBD
  • 31% use CBD for pain
  • 26.5% use CBD for anxiety/stress
  • 18% use CBD for sleep
  • 12.5% use CBD for depression 
  • 31% use CBD daily 

Leafreport noted that in many cases, CBD was being used to help with multiple conditions, such as depression and insomnia simultaneously.

Consumer preference 

When it comes to format, the survey revealed that 35% of respondents favored CBD-infused gummies, edibles, and beverages. Just over a quarter reports that they prefer oils and tinctures, followed by topicals coming in at 14%, and capsules at 12%. Just 10% of users said they vaped their CBD.

When buying CBD, many respondents indicated they weren’t necessarily looking for products with super high concentrations of CBD. Thirty-two percent said they sought out products containing 500mg-1000mg of CBD, 28% looked for products with less than 500 mg, 26% admitted that they didn’t check for CBD concentration, 9% desired products containing 1001-2500mg, and 5% sought potent CBD products with more than 2500 mg.


Image courtesy of Leafreport

Not surprisingly, dosage was all over the map, with 26% of respondents reporting that they take 5-10 mg and 22% admitting  they didn’t know how much they take because they didn’t check the dose.

About 17% of respondents said they took 10-20 mg, while 13% took less than 5 mg. 11% of the respondents took 20-40 mg, and a further 4% took 40-70 milligrams. Another 4% took more than 100 mg each time and 3% took 70-100 mg. 

When asked who recommended this dosage, 42% said they determined the dosage themselves based on trial and error. Just over 20% reported that they followed the dosage guidelines on the product.

Some respondents did seek out an expert, with 18% consulting, 11% discussing dosage with a cannabis industry professional and 8% either researching online or using a dosage calculator.


A majority (57%) of respondents indicated that they were satisfied with the dose, while 17% said they were not happy and had increased the dosage over time, followed by 16% who are still looking to achieve the right dosage and 10% actually decreased the dosage because the effects were too strong.

Due to the lack of standardized safe amounts of CBD, Leafreport created a dosing guide​ and recommends consumers take the “start low, go slow” approach.

Related news

Show more

Related products

show more

ADM Sustainability & Integrated Supply Chain

ADM Sustainability & Integrated Supply Chain

ADM: Gain an Edge with Global Consumer Trends | 07-Nov-2022 | Technical / White Paper

Wondering how to meet your climate goals? Find out how through increased investment in regenerative agriculture and other programs ADM can help you reduce...

2023 Global Consumer Trends Report

2023 Global Consumer Trends Report

ADM: Gain an Edge with Global Consumer Trends | 07-Nov-2022 | Insight Guide

Are you keeping up with the latest consumer trends? Uncover the 8 key global growth drivers shaping the future of innovation in ADM’s 3rd Annual Global...

Great mouth feel with plant-based appeal

Great mouth feel with plant-based appeal

ADM | 26-Oct-2022 | Case Study

Put Stabrium™ to work for you. After extensive development comes our Stabrium™ portfolio with the body, thickness and mouthfeel consumers expect in dairy...

Our supply chain delivers your climate goals.

Our supply chain delivers your climate goals.

ADM | 25-Oct-2022 | Product Brochure

We put food on tables the world over. So, we’re investing in building a more sustainable supply chain. Our supply chain starts with regenerative agriculture...

Related suppliers

Follow us


View more